Q3 FY2026 · ended Sep 30, 2026 · Revenue $410.14M, +15.6% YoY · Filed Oct 29, 2026
Penumbra, Inc (PEN) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $410.1 million and net income of $42.3 million. Free cash flow was $26.4 million. As of Sep 30, 2026 it held $673.6 million in cash and investments and $209.4 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alameda, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1321732
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $410.1M | $390.0M | $374.8M | $385.4M | $354.7M |
| Operating income | $50.7M | $41.0M | $38.2M | $59.2M | $48.8M |
| Net income | $42.3M | $34.8M | $32.6M | $47.3M | $45.9M |
| Diluted EPS | $1.07 | $0.88 | $0.82 | $1.20 | $1.17 |
| Operating cash flow | $41.5M | $46.1M | $87.0M | $86.5M | $58.3M |
| Free cash flow | $26.4M | $32.5M | $73.3M | $68.0M | $42.0M |
| Total assets | $2.0B | $2.0B | $1.9B | $1.8B | $1.7B |
| Total liabilities | $441.6M | $444.0M | $424.6M | $398.9M | $385.7M |
| Stockholders' equity | $1.6B | $1.5B | $1.5B | $1.4B | $1.4B |
| Cash and investments | $673.6M | $658.8M | $615.7M | $544.8M | $470.3M |
| Total debt | $209.4M | $212.7M | $216.2M | $219.7M | $217.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 29, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 7, 2026 | May 6, 2026 |
All 955 Penumbra, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.